Consensus report of the Fifth International Forum for Liver MRI.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23789662.
- Also identified by DOI 10.2214/AJR.12.9491.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This article reviews topics discussed during the Fifth International Forum for Liver MRI (with a focus on gadoxetic acid-enhanced MRI), which was held in Munich, Germany, in September 2011. Growing evidence shows that gadoxetic acid-enhanced MRI has high sensitivity and specificity for diagnosing liver tumors. Hepatobiliary phase imaging adds new information for the characterization of borderline lesions. However, there is a need to develop standardized criteria for interpretation of gadoxetic acid-enhanced MRI in patients with cirrhosis or other risk factors for hepatocellular carcinoma.
Medical subject headings
- Carcinoma, Hepatocellular
- Contrast Media
- Gadolinium DTPA
- Liver Neoplasms
- Magnetic Resonance Imaging